Notify me when Third Rock Ventures V, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Common Stock, $0.001 par value per share | 19.5% | $81.2M | 7.14M | Third Rock Ventures V, L.P. | Dec 31, 2024 | ||
| SEPN | Septerna, Inc. | Common Stock, $0.001 par value per share | 14% | $43.5M | 6.22M | 0% | Third Rock Ventures V, L.P. | Mar 31, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|